Further molecular analysis of tumor tissue by the amplification refractory mutation system (ARMS)—PCR demonstrated an exon 19 deletion of the epidermal growth factor receptor (EGFR) gene (Table 1). This evidence concerns the gene EGFR and neoplasm.